AcelRx Pharmaceuticals
ACRX
$0.58
Share price
0.17%
Change (1 day)
-86.82%
Change (1 year)
Categories
AcelRx Pharmaceuticals (ACRX) - Total liabilities
Total liabilities on the balance sheet as of June 2023 : $7.3 M
According to AcelRx Pharmaceuticals 's latest financial reports the company's total liabilities are $7.3 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
AcelRx Pharmaceuticals - Total liabilities on balance sheet (from 2009 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $25.67 M | -77.44% |
| 2021-12-31 | $0.11 B | -6.77% |
| 2020-12-31 | $0.12 B | -8.08% |
| 2019-12-31 | $0.13 B | 14.18% |
| 2018-12-31 | $0.11 B | 3.76% |
| 2017-12-31 | $0.11 B | 6.39% |
| 2016-12-31 | $0.10 B | 11.26% |
| 2015-12-31 | $94.67 M | 137.92% |
| 2014-12-31 | $39.79 M | 7.92% |
| 2013-12-31 | $36.87 M | 20.21% |
| 2012-12-31 | $30.67 M | 31.27% |
| 2011-12-31 | $23.36 M | -67.87% |
| 2010-12-31 | $72.72 M | 7.76% |
| 2009-12-31 | $67.48 M | 20.48% |
| 2008-12-31 | $56.01 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Cara Therapeutics
CARA | $25.45 M | 248.44% | 🇺🇸 USA |